| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/29/2004 | CA2242347C A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/29/2004 | CA2178604C Novel imidazole derivative and process for producing the same |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/29/2004 | CA2133563C Use of hydriodic acid as an aphrodisiac |
| 06/29/2004 | CA2105215C Novel oxazolidines |
| 06/24/2004 | WO2004052372A1 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2003100025A3 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003057200A3 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | US20040122218 Pyrrolopyridine potassium channel openers |
| 06/24/2004 | US20040122039 Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 06/24/2004 | US20040122035 selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase-5 (PDE5); sexual disorders, cardiovascular disorders; 1-(2H-benzo[d]1,3-dioxolan-5-yl)(1,2,3,4-tetrahydro- beta -carbolin-2-yl)-2-naphthyl ketone for example |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122006 such as 7-[(2-aminophenyl)sulfanyl]-2H-1,4-benzoxazin-3(4H)-one; oxidation/reduction; deblocking/deprotectiing; cardiovascular disorders |
| 06/24/2004 | US20040122001 Pharmaceutical compounds |
| 06/24/2004 | US20040120994 polymer matrix contains the sex hormone testosterone and a mixture of a penetration-enhancing substance selected from fatty alcohol esters and fatty acid esters, and at least one readily volatile penetration-enhancing agent |
| 06/24/2004 | US20040120970 vaccine is for administration in the submucosa of the labiae is an attenuated form of a horse pathogenic bacterium |
| 06/23/2004 | EP1430898A1 Receptor antagonist |
| 06/23/2004 | EP1430891A1 Oil-acid-emulsion for the treatment of joint diseases and for the stimulation of blood-circulation |
| 06/23/2004 | EP1430125A2 Sperm-specific cation channel, and uses therefor |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429778A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429760A1 Novel combination |
| 06/23/2004 | EP1429753A1 Pharmaceutical composition comprising gamma-butyrobetaine |
| 06/23/2004 | EP1429751A1 Salicylic acid salts, methods for the production and use thereof as medicaments |
| 06/23/2004 | EP1429602A1 Methods for treating disorders using plant extracts |
| 06/23/2004 | EP1189620B1 Formulation comprising testosteron undecanoate and castor oil |
| 06/23/2004 | EP1140108B1 Method and composition for treatment of female sexual dysfunction |
| 06/23/2004 | EP1076644B1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 06/23/2004 | EP1024801B1 Method for regulating size and growth of vascularized normal tissue |
| 06/23/2004 | EP0779889B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753336 Melanin concentrating hormone receptor ligands |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | CA2176926C .alpha.v.beta.3 integrin as a predictor of endometriosis |
| 06/22/2004 | CA2104793C Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
| 06/17/2004 | WO2004050679A2 Mutant glycoproteins |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050114A1 Novel agent for improving neurotransmission failure |
| 06/17/2004 | WO2004050075A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | WO2004050074A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | WO2004016256A3 AGONISM OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003070184A3 Sodium channel blockers |
| 06/17/2004 | WO2003053334A3 Compositions and methods for the diagnosis and treatment of tumor |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116699 Melanocortin receptor agonists |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseases |
| 06/17/2004 | US20040116534 Methods of treating and preventing narcolepsy using enantiomerically pure (s)-didesmethylsibutramine |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040116336 Peptide derivatives |
| 06/17/2004 | US20040116328 Condensed imidazole derivatives |
| 06/17/2004 | US20040115761 Polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040115259 a floating tablet including as active principle alfuzosin |
| 06/17/2004 | CA2507763A1 Fused 1,3-dihydro-imidazole ring compounds |
| 06/17/2004 | CA2507750A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | CA2485957A1 Protease inhibitor |
| 06/17/2004 | CA2469724A1 Mutant glycoproteins |
| 06/16/2004 | EP1428822A2 1-phenylpiperazine derivative as modulators of dopamine neurotransmission |
| 06/16/2004 | EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications |
| 06/16/2004 | EP1427857A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427830A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 06/16/2004 | EP1427808A1 Lactic acid producing bacteria for use as probiotic organisms in the human vagina |
| 06/16/2004 | EP1427748A1 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 06/16/2004 | EP1427734A1 GLYCINE-SUBSTITUTED THIENO 2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY |
| 06/16/2004 | EP1427733A1 Thieno 2,3-d]pyrimidines with combined lh and fsh agonistic activity |
| 06/16/2004 | EP1427436A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 06/16/2004 | EP1427433A1 Biodegradable implant comprising a polylactide polymer and a lh-rh analogue |
| 06/16/2004 | EP1427430A2 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary system caused by sex hormones |
| 06/16/2004 | EP1427424A2 Lpa receptor agonists and antagonists and methods of use |
| 06/16/2004 | EP1427412A1 Methods of treating cytokine mediated diseases |
| 06/16/2004 | EP1427407A2 Fatty amine drug conjugates |
| 06/16/2004 | EP1339406B1 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 06/16/2004 | EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors |
| 06/16/2004 | EP1244643B1 Tryptase inhibitors |
| 06/16/2004 | EP1119570B1 Tricyclic delta3-piperidines as pharmaceuticals |
| 06/16/2004 | EP0981354B1 Condensation polymer composition for preventing pregnancy |
| 06/16/2004 | CN1505630A Pyrazolo[1,5-a]pyridines and medicaments containing thereof |
| 06/16/2004 | CN1505627A Cyclic amp-specific phosphodiesterase inhibitors |
| 06/16/2004 | CN1505618A Dimeric isoflavones |